These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 23871879)

  • 1. The molecular basis for the inhibition of phosphodiesterase-4D by three natural resveratrol analogs. Isolation, molecular docking, molecular dynamics simulations, binding free energy, and bioassay.
    Zhao P; Chen SK; Cai YH; Lu X; Li Z; Cheng YK; Zhang C; Hu X; He X; Luo HB
    Biochim Biophys Acta; 2013 Oct; 1834(10):2089-96. PubMed ID: 23871879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moracin M from Morus alba L. is a natural phosphodiesterase-4 inhibitor.
    Chen SK; Zhao P; Shao YX; Li Z; Zhang C; Liu P; He X; Luo HB; Hu X
    Bioorg Med Chem Lett; 2012 May; 22(9):3261-4. PubMed ID: 22483586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and modelling studies of natural ingredients from Gaultheria yunnanensis (FRANCH.) against phosphodiesterase-4.
    Cai YH; Guo Y; Li Z; Wu D; Li X; Zhang H; Yang J; Lu H; Sun Z; Luo HB; Yin S; Wu Y
    Eur J Med Chem; 2016 May; 114():134-40. PubMed ID: 26978121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A combination of pharmacophore modeling, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on PDE4 enzyme inhibitors.
    Tripuraneni NS; Azam MA
    J Biomol Struct Dyn; 2016 Nov; 34(11):2481-92. PubMed ID: 26587754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacophore modeling, 3D-QSAR, and docking study of pyrozolo[1,5-a]pyridine/4,4-dimethylpyrazolone analogues as PDE4 selective inhibitors.
    Tripuraneni NS; Azam MA
    J Mol Model; 2015 Nov; 21(11):289. PubMed ID: 26499496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel phosphodiesterase-4D inhibitors prescreened by molecular dynamics-augmented modeling and validated by bioassay.
    Li Z; Cai YH; Cheng YK; Lu X; Shao YX; Li X; Liu M; Liu P; Luo HB
    J Chem Inf Model; 2013 Apr; 53(4):972-81. PubMed ID: 23517293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insight into Inhibitory Mechanism of PDE4D by Dietary Polyphenols Using Molecular Dynamics Simulations and Free Energy Calculations.
    Furlan V; Bren U
    Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33806914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural phosphodiesterase-4 (PDE4) inhibitors from Crotalaria ferruginea.
    Liu YN; Huang YY; Bao JM; Cai YH; Guo YQ; Liu SN; Luo HB; Yin S
    Fitoterapia; 2014 Apr; 94():177-82. PubMed ID: 24594242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the Role of Water Molecules in the Ligand Binding Domain of PDE4B and PDE4D: Virtual Screening Based Molecular Docking of Some Active Scaffolds.
    Singh P; Mishra M; Agarwal S; Sau S; Iyer AK; Kashaw SK
    Curr Comput Aided Drug Des; 2019; 15(4):334-366. PubMed ID: 30394213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based design of selective phosphodiesterase 4B inhibitors based on ginger phenolic compounds.
    Xing M; Akowuah GA; Gautam V; Gaurav A
    J Biomol Struct Dyn; 2017 Oct; 35(13):2910-2924. PubMed ID: 27608741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular insight into the differential anti-androgenic activity of resveratrol and its natural analogs: in silico approach to understand biological actions.
    Chakraborty S; Kumar A; Butt NA; Zhang L; Williams R; Rimando AM; Biswas PK; Levenson AS
    Mol Biosyst; 2016 May; 12(5):1702-9. PubMed ID: 27063447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discover natural compounds as potential phosphodiesterase-4B inhibitors via computational approaches.
    Li J; Zhou N; Liu W; Li J; Feng Y; Wang X; Wu C; Bao J
    J Biomol Struct Dyn; 2016 May; 34(5):1101-12. PubMed ID: 26159554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular basis for the selectivity of tadalafil toward phosphodiesterase 5 and 6: a modeling study.
    Huang YY; Li Z; Cai YH; Feng LJ; Wu Y; Li X; Luo HB
    J Chem Inf Model; 2013 Nov; 53(11):3044-53. PubMed ID: 24180640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of triazines as potent, selective and orally active PDE4 inhibitors.
    Gewald R; Grunwald C; Egerland U
    Bioorg Med Chem Lett; 2013 Aug; 23(15):4308-14. PubMed ID: 23806553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and optimization of triazine derivatives as ROCK1 inhibitors: molecular docking, molecular dynamics simulations and free energy calculations.
    Shen M; Zhou S; Li Y; Pan P; Zhang L; Hou T
    Mol Biosyst; 2013 Mar; 9(3):361-74. PubMed ID: 23340525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study on the interactions of trans-resveratrol and curcumin with bovine α-lactalbumin by spectroscopic analysis and molecular docking.
    Mohammadi F; Moeeni M
    Mater Sci Eng C Mater Biol Appl; 2015 May; 50():358-66. PubMed ID: 25746281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for the selective inhibitors of MMP-9 from natural products based on pharmacophore modeling and molecular docking in combination with bioassay experiment, hybrid QM/MM calculation, and MD simulation.
    Hou J; Zou Q; Wang Y; Gao Q; Yao W; Yao Q; Zhang J
    J Biomol Struct Dyn; 2019 Aug; 37(12):3135-3149. PubMed ID: 30079817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular dynamics simulation and free energy calculation studies of kinase inhibitors binding to active and inactive conformations of VEGFR-2.
    Wu X; Wan S; Wang G; Jin H; Li Z; Tian Y; Zhu Z; Zhang J
    J Mol Graph Model; 2015 Mar; 56():103-12. PubMed ID: 25594497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing protein-ligand binding modes with computational tools: the case of PDE4B.
    Çifci G; Aviyente V; Akten ED; Monard G
    J Comput Aided Mol Des; 2017 Jun; 31(6):563-575. PubMed ID: 28534194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into PDE4B inhibitor selectivity: CoMFA analyses and molecular docking studies.
    Guariento S; Bruno O; Fossa P; Cichero E
    Mol Divers; 2016 Feb; 20(1):77-92. PubMed ID: 26290462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.